Three new CEOs Unplugged sessions have been added to the #MTC26 agenda, bringing together influential leaders from across medtech and health care delivery for candid conversations you won’t find anywhere else.
These executive-level discussions will explore the financial, business, and technology forces influencing investment, innovation, partnerships, and growth across the industry, only at The MedTech Conference, October 18-21 in Boston.
How Provider Economics Are Reshaping Care Delivery and the Implications for MedTech
Sponsored by The Alexander Group
This unscripted executive conversation will explore how provider financial pressures have influenced decision-making throughout 2026 and what those realities mean heading into 2027. Drawing on recent provider research and real-world leadership experience, the discussion will examine how economic constraints are affecting capital investments, AI adoption, workforce decisions and care delivery models—and how those changes are influencing what providers expect from their MedTech partners.
Whether you’re shaping corporate strategy, leading commercial teams, planning product investments or strengthening health system partnerships, this session will provide valuable executive perspectives on where provider priorities are headed—and how medtech leaders can position their organizations for long-term success.
Featured Speakers
Michael White (Moderator)
Principal, Alexander Group
Anne Klibanski, MD
President and Chief Executive Officer, Mass General Brigham
Michael Mahoney
Chairman and Chief Executive Officer, Boston Scientific
Geoff Martha
Chairman and Chief Executive Officer, Medtronic
Resilient By Design: Navigating Uncertainty in MedTech Supply Chains
Sponsored by Kearney
Geopolitical uncertainty is reshaping the foundations of global supply chains. For medtech companies, rising tariffs, regionalization pressures, natural disasters, climate change, and volatility in critical inputs are forcing a shift from cost-optimized networks to resilience-driven strategies. Supply chain decisions are no longer purely operational—they are increasingly central to enterprise risk management and long-term growth.
This session will examine how medtech CEOs are embedding uncertainty drivers into strategic planning and redesigning their supply chains to operate in an era of persistent disruption. Discussion topics will include managing single-source risk, balancing global efficiency with regional proximity, and identifying “no-regret” moves across a range of future scenarios. Panelists will also share how advanced analytics and AI are enhancing visibility and enabling faster, more informed decision-making in complex and rapidly changing environments.
Featured Speakers
Erik Blazic (Moderator)
Partner and Global Lead, Medtech, Kearney
John Kowal
President, Siemens Medical Solutions USA, Inc. & Head of the Americas, Siemens Healthineers
Christopher Toth
Chief Executive Officer, Vantive
From Device Company to Healthcare Platform: The New MedTech Playbook
Sponsored by Premier, Inc.
Medtech companies are evolving far beyond traditional device manufacturing. Today’s leaders are building integrated ecosystems that combine hardware, software, data, and services to deliver continuous value across the care journey.
In this candid CEO conversation, industry leaders will discuss how they are transforming their organizations into healthcare platforms-redefining business models, forging new partnerships, and creating technology-enabled solutions that extend well beyond the device itself. From remote monitoring and AI-enabled insights to digital services and value-based care alignment, this session will explore how medtech companies are positioning themselves for the next decade of healthcare delivery.
Featured Speakers
Myla Maloney (Moderator)
Chief Growth Officer, PAS, Premier, Inc.
Tom Polen Jr.
Chairman, Chief Executive Officer and President, BD
Deepak Nath
Chief Executive Officer, Smith+Nephew
Michael Parden
Chief Executive Officer, B.Braun of America, Inc.
These are just three of the thirteen CEOs Unplugged sessions you’ll find at The MedTech Conference. This year’s agenda features 400+ industry experts and timely discussions spanning AI and digital health, medtech investment, commercialization strategies, global market expansion, diagnostics, health access and the policy, business and technology trends shaping the future of the industry.
Explore the agenda and join thousands of medtech leaders October 18–21 in Boston for the industry’s can’t-miss event. Register by August 6 to take advantage of early bird pricing.